Naturex disputes Vitiva market share claim
Naturex said that Vitiva is certainly not a leading company in the rosemary extract market.
02/11/05 In a recent press release, Mr. Ohad Cohen, CEO of Vitiva, stated that, “Vitiva owns 70% of today’s market share of active ingredients of Rosemary extracts in Europe.” President and CEO of Naturex Jacques Dikansky responded by stated that, “This information is incredibly untrue and it is an absolutely false representation of this company. Vitiva is certainly not a leading company in this market”.
Moreover, Dikansky pointed out, a group constituted by the four main producers of Rosemary extracts in Europe (including Naturex) has been created in order to register Rosemary extracts as antioxidants with the European Legislation. “Vitiva is not a member of this group and has never been involved in the funding of any of the registration processes or clinical / toxicological studies that relate to this project”, Dikansky commented.
www.naturex.com
Upcoming webinars
Probiotic Innovation in Menopause: Expert Perspectives and Clinical Evidence
AB-BIOTICS Kaneka Probiotics
Upliving with Postbiotics: Discover the power of LAC-Living+ in Mood
Morinaga Milk Industry Co., Ltd.
Bioavailability Breakthrough: Smarter Supplementation for Plant-Rich Diets
Balchem Human Nutrition & Health
